Skip to main content
Premium Trial:

Request an Annual Quote

Newly Sequenced Influenza Strains Shed Additional Light on How Flu Viruses Evolve

NEW YORK, Oct. 7 (GenomeWeb News) - With flu season around the corner, the multi-institutional Influenza Genome Sequencing Project has completed the sequencing of 209 varieties of influenza, the US National Institutes of Health said yesterday.


The data, published in the Oct. 5 issue of Nature, "give us the most comprehensive picutre to date of how influenza viruses evolve and are transmitted throughout human populations," Anthony Fauci, director of the US National Institute of Allergy and Infectious Diseases, said in the statement.


The effort yielded 2.8 million sequenced nucleotides, which will be made available for researchers through GenBank, the NIH said. The research explains why the 2003-2004 flu vaccine was only partially successful -- competing strains of the virus circulated in the human population at different times of the flu season, the NIH said.


Institutions involved in the project included: the National Institute of Allergy and Infectious Disease; the National Center for Biotechnology Information; the Wadsworth Center of the New York State Department of Health in Albany; and The Institute for Genomic Research in Rockville, Md.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.